An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 248,000 of its own ordinary shares as part ...

The GSK site ceased production earlier this year [] A pharmaceutical factory which ceased production earlier this year has ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...

CNW/ - Dalhousie University, in collaboration with Nova Scotia Health's INSPIRED COPD Outreach Program, the Nova Scotia ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

A BAE Systems spokesperson said: “We can confirm BAE Systems has acquired the former GSK pharmaceutical manufacturing site in Ulverston, Cumbria. The site offers many redevelopment opportunities to ...

GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...

US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...

The new approval completes a surprise turnaround for Blenrep, which was initially cleared in 2020 but pulled from the market ...

The approval is based on data from a Phase III trial evaluating patients who had received two or more previous treatments.

Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the company said on Thursday, clearing the way for its return to the ...